Oncotelic Therapeutics, Inc. cotiza a 0.02 USD y tiene una capitalización bursátil de $9M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing OXi4503 for the treat…
| Periodo | 2023-11 | 2023-08 | 2023-04 | 2022-11 |
|---|---|---|---|---|
| Real | — | $-0.02 | $-0.01 | — |
| Estimado | — | — | — | — |
| Sorpresa | — | — | — | — |
| Métrica | OTLC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | 94.9% | -40.4% | +135.3% |
| ROA | 63.4% | -32.0% | +95.4% |
| Current Ratio | 0.07 | 2.84 | -2.77 |
| Debt / Equity | — | 0.28 | — |